Uptool | $6,000,000 | (Feb 10, 2026)
BotGauge AI | $2,000,000 | (Feb 10, 2026)
Linkup(US) | $10,000,000 | (Feb 10, 2026)
PolarityTE
United States
- Salt Lake City, Utah
- 22/05/2024
- Unknown
- $22,500,000
PolarityTE, Inc., headquartered in Salt Lake City, Utah, is a biotechnology company developing regenerative tissue products. PolarityTE's first regenerative tissue product is SkinTE®. PolarityTE has an open investigational new drug application (IND) for SkinTE® with the U.S. Food and Drug Administration (FDA) and is now pursuing the first of two pivotal studies on SkinTE® needed to support a biologics license application (BLA) for a chronic cutaneous ulcer indication. SkinTE® is available for investigational use only. Learn more at www.PolarityTE.com.
- Industry Biotechnology Research
- Website https://www.polarityte.com/
- LinkedIn https://www.linkedin.com/company/polarityte/
Related People
John StetsonFounder
United States -
Fort Lauderdale, Florida
John Stetson is the Founder and Managing Member of Sunset Bay Capital, LLC, a multi-strategy Private Equity Firm based in Fort Lauderdale, FL. Mr. Stetson serves as Chief Executive Officer of PolarityTE, a biotechnology company developing regenerative tissue products, and Stoner’s Pizza Joint, a 40-unit national pizza franchisor. In addition, he serves as a Special Advisor and Board Member to portfolio companies.
He has held Chief Financial Officer and Director positions for two Nasdaq listed companies. As a public company executive, he has been responsible for raising over $250 million in financing. He received his BA in Economics from the University of Pennsylvania.
Phylo | $13,500,000 | (Feb 10, 2026)
pHathom Technologies, Inc | $4,000,000 | (Feb 10, 2026)
microsynetics GmbH | $10,000,000 | (Feb 10, 2026)
Modveon | $10,000,000 | (Feb 10, 2026)
Qontext | $2,700,000 | (Feb 10, 2026)
Bound | $24,500,000 | (Feb 10, 2026)
Sentra(US) | $5,000,000 | (Feb 10, 2026)
Nixtla | $16,000,000 | (Feb 6, 2026)
Advance | $8,550,000 | (Feb 6, 2026)